l-carnitine after food how long to wait for Weight Loss: Results 1 Month How Long Should You Take

Rebouche, C.A

The efficacy of silymarin in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial

J.ZipfelW

Disclosures: Won-Mook Choi: Nothing to Disclose, Subin Heo: Nothing to Disclose, Jiwon Yang: Nothing to Disclose, Jonggi Choi: GILEAD SCIENCE: Grant/Research Support, Young-Suk Lim: Nothing to Disclose 729 TARGETING LOWER SERUM ALBUMIN WITH LONG TERM ALBUMIN ADMINISTRATION IMPROVES OUTCOMES OF RECURRENT ASCITES IN PATIENTS WITH DECOMPENSATED CIRRHOSIS- FINAL RESULTS OF THE RANDOMISED CONTROLLED TRIAL Rakhi Maiwall 1 Samba Siva Rao Pasupuleti 2 Sherin Thomas 3 jaswinder singh Maras 3 Sukriti Baweja 3 Anupam Kumar 3 Jaya Benjamin 3 Harsh Vardhan Tevethia 3 Kanika Jain 3 Puja Bhatia Kapoor 3 Bindiya Arora 3 Varsha Shasthry 1 Shiv Kumar Sarin 3 , 1 Institute Of Liver And Biliary Sciences, 2 Mizoram University, Pachhunga University College Campus, Aizawl, 3 Institute of Liver & Biliary Sciences Background: Long- term albumin (LTA) and targeting serum albumin of 4 gm/dl improves major adverse liver outcomes (MALO) in cirrhosis patients with ascites